The Latest in the Suboxone Mass Tort: Key Developments, Payout Estimates, and Emerging Investigations
The Suboxone mass tort litigation continues to evolve in 2024 as the multidistrict litigation (MDL) progresses through critical stages. With Defendant Indivior’s Motion to Dismiss (MTD) pending, the legal landscape surrounding Suboxone is at a crucial point, especially for plaintiffs who allege the drug caused severe side effects like tooth decay. This litigation is gaining momentum, with law firms expanding their focus on product defects and the long-term impact on patients.
Defendant’s Motion to Dismiss: A Familiar Preemption Defense
Indivior’s MTD is rooted in an argument commonly seen in pharmaceutical cases: preemption. The company argues that the plaintiffs’ state law claims for failure-to-warn and design defects are preempted by federal law because the Suboxone label had FDA approval. However, plaintiffs counter that Indivior had a continuing obligation to update the label as new safety risks became evident, particularly concerning the widespread reports of dental damage associated with the drug.
The court’s ruling on this motion will significantly impact whether the case proceeds to discovery, where further evidence could emerge regarding Indivior’s knowledge of Suboxone’s risks and its failure to adequately inform the public.
Discovery and Its Importance for Suboxone Cases
Should the court deny the MTD, the litigation will advance into discovery. This phase is crucial for gathering evidence, including internal documents from Indivior, which could shed light on what the company knew about Suboxone’s risks and when it became aware of them. Thousands of plaintiffs have claimed that Suboxone caused severe dental issues, and discovery will likely focus on whether Indivior neglected to warn patients and healthcare providers about these long-term effects.
Discovery could also delve into the Suboxone Film litigation. The Cook v. Indivior Inc. et al. case, filed by Levin Rojas Camassar & Reck LLC, focuses on liability surrounding Suboxone Film. This could provide further insights into product defects, adverse effects, or issues with marketing practices related to the drug.
Estimated Settlement Payouts and Trial Value for Suboxone Lawsuits
Suboxone lawsuits related to dental injuries are expected to see substantial payouts. Settlement estimates range from $30,000 to $150,000, with law firms anticipating that many of these cases could settle to avoid prolonged court battles.
However, the trial value of Suboxone lawsuits could be much higher. Miller & Zois, a mass tort law firm, suggests that cases going to trial could result in jury verdicts ranging from $500,000 to $1 million. In cases where punitive damages are awarded, the compensation could rise significantly, especially if the plaintiffs can prove that Indivior acted with negligence or intentional misconduct.
Recent Investigations: Focus on Dental Injuries
Law firms are increasingly focusing on dental complications as a key issue in the Suboxone litigation. For example, Sokolove Law launched a Suboxone Dental Issues Investigation on September 16, 2024, signaling that firms are zeroing in on the connection between Suboxone and severe tooth decay. The increased attention on dental damage reflects the emerging importance of this side effect in the mass tort landscape.
What’s Next in the Suboxone MDL?
As the litigation progresses and the court’s ruling on the MTD looms, law firms and plaintiffs are preparing for the potential discovery phase. The outcome of this motion will determine whether the case moves forward, and if so, it could reveal crucial information about Indivior’s handling of Suboxone’s risks.
With dental issues at the forefront, this mass tort is likely to see substantial settlements and trial awards. Plaintiffs and legal experts are watching closely for developments that could influence settlement negotiations and trial strategies.
Partner with Blue Sky Legal for Suboxone Client Acquisition Campaigns
At Blue Sky Legal, we specialize in connecting law firms with the right plaintiffs in mass tort cases like Suboxone. With dental complications emerging as a key issue, we can help your firm build a robust Suboxone caseload through strategic marketing campaigns. Our expertise in digital and TV campaigns ensures that your firm reaches qualified leads efficiently.
If you’re looking to grow your Suboxone client base, contact Blue Sky Legal today to discuss how we can help your firm with tailored marketing solutions.
